Add BrightSurf on Google Email

Future Science Group


Research in Regenerative Medicine proposes a quality control framework for umbilical cord blood-sourced allografts

A recent study proposes a quality control framework for umbilical cord blood-sourced allografts, outlining future safety and potency benchmarks. The study identifies a unique liaison among the UCB-sourced allograft, host mesenchymal stem cells, and their secreted exosomes that influences tissue regeneration in vivo.

SourceFuture Science Group·JournalRegenerative Medicine·DateJul 22, 2019

A new tool for improving uterine transplant surgery

A new tool using biomedical photonics is being explored to improve uterine transplant surgery by providing real-time data on tissue perfusion and viability. The study found that multispectral imaging proved effective in mapping oxygen saturation over the entire graft, demonstrating advantages over existing methods.

SourceFuture Science Group·JournalFuture Science OA·DateFeb 12, 2018

Looking to the future of organs-on-chip

Advances in lab-on-a-chip technology allow for more accurate analysis and translation of research to the clinic. Organ-on-a-chip (OOAC) technology has great potential in helping screen drugs in a more cost-effective manner, reducing failures and costs.

SourceFuture Science Group·JournalFuture Science OA·DateJun 6, 2017

Journal of Comparative Effectiveness research discusses oncology treatment sequences

The Journal of Comparative Effectiveness Research discusses new recommendations from the Center for Medical Technology Policy's Green Park Collaborative for evaluating oncology treatment sequences. The framework developed by GPC-USA aims to fill evidence gaps and identify patient-important outcomes, ultimately improving cancer patient ...

SourceFuture Science Group·JournalJournal of Comparative Effectiveness Research·DateDec 17, 2015

Exploring current state of knowledge about mild cognitive impairment in Parkinson's disease

The article reviews lessons learned from Alzheimer's disease research to advance the development of screening and diagnostic algorithms for Parkinson's disease. It explores MCI-AD research, clinical trials incorporating biomarkers and genetics, and emerging therapeutic strategies targeting specific biological mechanisms.

SourceFuture Science Group·JournalNeurodegenerative Disease Management·DateNov 4, 2015